Two Sigma Advisers
ANIP icon

Two Sigma Advisers’s ANI Pharmaceuticals ANIP Stock Holding History

Two Sigma Advisers’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,500
Closed -$1.62M – 130
2025
Q4 		$1.62M Sell
20,500
-4,000
-16% -$346K ﹤0.01% 1272
2025
Q3 		$2.24M Buy
+24,500
New +$2M ﹤0.01% 1093
2024
Q2 		– Sell
-14,100
Closed -$975K – 2427
2024
Q1 		$975K Sell
14,100
-2,900
-17% -$175K ﹤0.01% 1589
2023
Q4 		$937K Buy
17,000
+9,200
+118% +$507K ﹤0.01% 1672
2023
Q3 		$453K Sell
7,800
-600
-7% -$34.6K ﹤0.01% 1828
2023
Q2 		$452K Buy
8,400
+3,300
+65% +$146K ﹤0.01% 1844
2023
Q1 		$203K Sell
5,100
-1,600
-24% -$67.5K ﹤0.01% 2264
2022
Q4 		$270K Sell
6,700
-12,000
-64% -$451K ﹤0.01% 2101
2022
Q3 		$601K Sell
18,700
-34,500
-65% -$1.18M ﹤0.01% 1765
2022
Q2 		$1.58M Sell
53,200
-32,300
-38% -$932K ﹤0.01% 1334
2022
Q1 		$2.4M Sell
85,500
-1,300
-1% -$48.5K 0.01% 1154
2021
Q4 		$4M Buy
86,800
+48,800
+128% +$2.1M 0.01% 865
2021
Q3 		$1.25M Sell
38,000
-9,600
-20% -$298K ﹤0.01% 1513
2021
Q2 		$1.67M Sell
47,600
-7,800
-14% -$265K ﹤0.01% 1386
2021
Q1 		$2M Sell
55,400
-1,600
-3% -$50.1K 0.01% 1270
2020
Q4 		$1.66M Buy
57,000
+1,500
+3% +$43K ﹤0.01% 1351
2020
Q3 		$1.57M Buy
55,500
+14,400
+35% +$429K ﹤0.01% 1287
2020
Q2 		$1.33M Buy
+41,100
New +$1.47M ﹤0.01% 1435

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers's ANIP Position: Q1 2026 in Review

Two Sigma Advisers sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 20,500 shares — an estimated $1.62M sold.

Two Sigma Advisers first reported a position in ANIP in Q2 2020 and held it in 18 quarters. The position peaked at $4M in Q4 2021. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Two Sigma Advisers reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 20,500 ANI Pharmaceuticals shares in Q1 2026, an estimated $1.62M.
  • Two Sigma Advisers first reported a position in ANI Pharmaceuticals in Q2 2020 and held it in 18 quarters.
  • Two Sigma Advisers's ANI Pharmaceuticals position peaked at $4M in Q4 2021.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.